IGFR-1 agonist (Peptimetic) (Antyra)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGFR-1 agonist (Peptimetic) (Antyra)
Drug Alias NameN/A
ClassificationSmall molecules > PeptidomimeticBiologics
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAntyra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntyra Inc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A